Summary of Study ST001779

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001132. The data can be accessed directly via it's Project DOI: 10.21228/M8CQ5F This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001779
Study TitleUntargeted Metabolomics analysis of A549 treated with 0.5 mM extracellular ATP and 10 ng/ml TGF-beta
Study TypeUntargeted metabolomics analysis in lung cancer cells
Study SummaryControl, 0.5 mM extracellular ATP and 10 ng/ml TGF-beta were used to treated 5 million A549 lung cancer cells in vitro for 2, 6 and 12 hours. The untargeted metabolomics analysis was performed on the cell lysates. The main objective of the study was to determine changes in metabolite abundances in lung cancer after treatment with extracellular ATP and TGF-beta (a known EMT inducer).
Institute
Ohio University
DepartmentBiological Sciences
LaboratoryDr. Xiaozhuo Chen, Edison biotechnology Institute
Last NameShriwas
First NamePratik
AddressRoom 425, Parks Hall, College of Pharmacy, Ohio State University, Columbus Ohio. 43210
Emailps774614@ohio.edu
Phone7406033801
Submit Date2021-04-04
Num Groups7
Raw Data AvailableYes
Raw Data File Type(s)mzXML
Analysis Type DetailLC-MS
Release Date2021-05-21
Release Version1
Pratik Shriwas Pratik Shriwas
https://dx.doi.org/10.21228/M8CQ5F
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Factors:

Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Treatment
SA16502512h ATP_212h ATP
SA16502612h ATP_312h ATP
SA16502712h ATP_612h ATP
SA16502812h ATP_112h ATP
SA16502912h ATP_412h ATP
SA16503012h ATP_512h ATP
SA16503112h TGF-β_412h TGF-β
SA16503212h TGF-β_312h TGF-β
SA16503312h TGF-β_212h TGF-β
SA16503412h TGF-β_512h TGF-β
SA16503512h TGF-β_612h TGF-β
SA16503612h TGF-β_112h TGF-β
SA1650372h ATP_42h ATP
SA1650382h ATP_12h ATP
SA1650392h ATP_32h ATP
SA1650402h ATP_52h ATP
SA1650412h ATP_22h ATP
SA1650422h ATP_62h ATP
SA1650432h TGF-β_42h TGF-β
SA1650442h TGF-β_52h TGF-β
SA1650452h TGF-β_62h TGF-β
SA1650462h TGF-β_22h TGF-β
SA1650472h TGF-β_32h TGF-β
SA1650482h TGF-β_12h TGF-β
SA1650496h ATP_46h ATP
SA1650506h ATP_36h ATP
SA1650516h ATP_16h ATP
SA1650526h ATP_26h ATP
SA1650536h TGF-β_46h TGF-β
SA1650546h TGF-β_16h TGF-β
SA1650556h TGF-β_36h TGF-β
SA1650566h TGF-β_26h TGF-β
SA165057Control_2Control
SA165058Control_3Control
SA165059Control_4Control
SA165060Control_1Control
Showing results 1 to 36 of 36
  logo